Presenter Disclosure Information William Hawkins Chairman and CEO, Medtronic Inc. FINANCIAL DISCLOSURE: Chairman and CEO, Medtronic Inc. UNLABELED/UNAPPROVED.

Slides:



Advertisements
Similar presentations
OUR STRATEGIC PLANNING JOURNEY. The Department of Medicine Strategic Plan  Our roadmap for the future  It will shape and guide what the Department of.
Advertisements

ROLE OF THE PHYSICIAN IN THE APPROVAL PROCESS Stephanie de Bono MD PhD Medical Advisor, Eli Lilly.
PROFESSIONAL NURSING PRACTICE
Personal financial benefit or economic interest from one’s position that may inappropriately: influence the employee’s judgment compromise the employee’s.
The evolving role of real-world evidence to support policy and practice CADTH 2015.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
William H. Maisel, MD, MPH Director, Medical Device Safety Institute Beth Israel Deaconess Medical Center Statement to the FDA Risk Communication Advisory.
About CQC Sarah Seaholme Ram Sooriah 1 1.
Michael A. Mussallem Chairman and CEO Edwards Lifesciences Leading the fight against advanced cardiovascular disease.
What Patients Need and Want to Know from their Physicians FDA Perspective Brian Lewis, MD, Medical Reviewer, FDA Division of Cardiovascular Devices Electrophysiologist,
Academia, Healthcare Providers, and the Industry Three Different Worlds? Three Different Sets of Goals? Sheldon Kong, PhD Senior Director, Outcomes Research.
Access to Medicine Index 3 rd International Conference for Improving the Use of Medicines Poster 599 Tuesday 15 th November 2011.
The Health Care Sector Analysts: Heather Hund and Emily Butler.
Presented By Sheila Lucas Ferris State University NURS 511
Challenges of a Harmonized Global Safety Regime Jacques Repussard Director General IRSN IAEA 2007 Scientific Forum.
Internship Experience At Medtronic Inc.
Strategy and Innovation Workgroup: Recommendations on the Federal Health IT Strategic Plan March 4, 2015 David Lansky, Chair Jennifer Covich,
Physician ‘Alignment’ Achieving Cultural Synergy in the Pursuit of Clinical Excellence Mississippi Healthcare Executives Summer Meeting June 5 & 7, 2013.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
Standards for Commercial Support: Standards to Ensure Independence in CME Activities SM Case Studies.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Innovation in Services Winter 2011 Professor Nina Ziv Polytechnic Institute of NYU Professor Nina Ziv Polytechnic Institute of NYU.
OntarioMD’s EMR Maturity Model Advancing Optimization and Use Ontario College of Family Practice Annual Scientific Assembly Presented By: Darren Larsen,
Presenter Title Presenter name. Living Our Mission in All We Do alleviate pain restore health extend life −written in 1960.
C ENTURY 21 A CCOUNTING © South-Western, Cengage Learning C H A R A C T E R C O U N T S CHAPTER 5 Business Codes of Conduct.
OntarioMD’s EMR Maturity Model & Reporting Advancing Optimization and Use e-Health 2013 Accelerating Change Conference Presented By: Darren Larsen, MD,
2009 Health Care Forecast Conference Mike Mussallem Chairman and CEO, Edwards Lifesciences Chairman of the Board, AdvaMed 2009 Health Care Forecast Conference.
Ms Rebecca Brown Deputy Director General, Department of Health
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
Transparency in Grants and Gifts Pfizer Approach Cathryn Clary, MD VP, US External Medical Affairs.
Ethics, Business, Innovation Andreas Loefler Adrian Cosenza Australia.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
The Purchasing Influence of Critical Care Nurses Presented by: Brian Carlson.
Copyright © Houghton Mifflin Company. All rights reserved.
16 February, 2003medXchange Private & Confidential 1 Implant Register & Patient Implant Profile for: Orthopaedic, Cardiovascular, Diabetology.
+ Role of Industry in Clinical Care, Research, and Education.
MEDTRONIC Fall Foundations 2014 | Business Acumen.
Setting the Scene: The Role of Ethics and Compliance in the Biopharmaceutical Market.
Confidential. This presentation is provided for the recipient only and cannot be reproduced or shared without Tennova Healthcare, Inc.’s express consent.
Transforming Patient Experience: The essential guide
Heart Failure Devices: Staying Connected Lisa D. Rathman, MSN, CRNP, CCRN, CHFN The Heart Group of Lancaster General Health Lancaster, PA.
rehabilitation services
Dorset Clinical Commissioning Group Dr Paul French.
ACCME at the International Pharmaceutical Compliance Summit Philadelphia March 2005.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Lilly Answers that Matter. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical.
Leadership in Action Minnesota Bridges to Excellence.
Integrating Mental Health Care, Education and Research Glenda MacQueen Vice Dean, Cumming School of Medicine University of Calgary.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
U.S. Interventional Cardiology Markets Changing Demographic Conditions and New Market Opportunities to Boost Growth “Greater incidence of cardiovascular.
1 Compliance vs. the Law Department: How to Work Together Michael Dusseau Senior Director, Compliance North America Schering-Plough David Ralston, Esq.
Equality Standard Equality, Diversity and Inclusion Equality Standard Equality, Diversity and Inclusion Equality Delivery System (EDS2) 2015/18 Ricky Somal:
This study proposes to explore the concept of empowerment combined with the clinical experience on final year nursing students.This study proposes to explore.
V Cardiac Equipment Market Size, Share, Global Trends, Company Profile, Demand, Insights, Analysis, Research, Report, Opportunities, Forecast,
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
Partners in Progress: Deciding to Participate in Parkinson’s Clinical Research.
Conferenceboard.ca Aligning, Foreseeing, and Optimizing HTA in Canada 2016 CADTH Symposium April 12, 2016 Dr. Gabriela Prada Director, Health Innovation.
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
CLI and Device Intervention Across the Pacific – An FDA View
Disclosure UK Talking about Transparency.
Health Technology Assessment
Copyright © Houghton Mifflin Company. All rights reserved.MGT437
Disclosure UK Talking about Transparency.
The Role of Data and Analytics in the Healthcare Ecosystem
Compliance and the Digitalization Example of Healthcare Sector
Clinical Research Services.  It is very important phase in medical science as it determines the safety and effectiveness of medications and treatment.
Presentation transcript:

Presenter Disclosure Information William Hawkins Chairman and CEO, Medtronic Inc. FINANCIAL DISCLOSURE: Chairman and CEO, Medtronic Inc. UNLABELED/UNAPPROVED USES DISCLOSURE: N/A

Bill Hawkins Chairman and CEO, Medtronic November 16, 2009 Collaboration, Innovation and Restoring the Public Trust

Medical technology has enabled remarkable advances in the treatment of chronic diseases Implantable cardiac pacemaker Heart valves Implantable defibrillator Coronary stents Balloon angioplasty CAT scan Cardiac resynchronizationPerfusion systems Beating heart surgery Transvenous leads External pacemaker Insulin pumps MRI & advanced imaging 60% reduction! YEAR DEATHS PER 100,000

Collaboration is vital to the medical technology “innovation ecosystem” Regulators Medical Associations Policymakers Clinical Community Hospitals Academia Industry Advocacy

Physician-industry collaboration plays a critical role Physician collaboratio n Invention and New Ideas Selection Criteria and Indications Implantation Techniques and Technologies Clinical Insights Product Improvement Clinical Trials and Regulatory Support Training and Education Long-term Performance Assessment

Many of today’s most important medical devices are the result of collaborative innovation with physicians Diabetes Cardiovascular Disease Cardiac Rhythm Disorders Neurological Disorders Spinal Conditions Musculoskeletal Trauma

This is particularly true in the areas of education and training and essential to the well-being of patients Different from pharmaceuticals “Bedside to bench to bedside” Therapies are sophisticated and procedure-based Expert training optimizes therapy effectiveness Demanded for patient safety

Trust in this model has been eroded as a result of highly publicized conflicts of interest TUESDAY, AUGUST 18, 2009 Probing Doctors’ Ties to Industry By Ibby Caputo Report decries drug makers’ perks for MDs; Providers of care are urged to shun financial benefits By Matthew Perrone April 29, 2009 Side Effects Are Doctors’ Loyalties Divided? Faculty disclose outside payments Some UW doctors get 6-figure sums from drug, medical firms By John Fauber JUNE 21, 2009 JAN. 27, 2009 Lawmakers Reintroduce Bill on Industry-Physician Gifts Grassley works to disclose financial ties between drug companies and doctors JAN. 22, 2009 Senator Chuck Grassley News Release TUESDAY, MAY 19, 2009 Senator Asks About Doctor Who Army Says Falsified G.I. Study By Barry Meier and Duff Wilson

Medtronic has always been a leader in this area Aligned with our mission Defines our culture and values Cornerstone of our ethics and compliance program Provides clear policies and guidance for business practices, including our customer interactions Required for all employees worldwide Early champion: AdvaMed Code of Ethics

As an industry we have made progress… Edwards Lifesciences to Disclose Financial Relationships with U.S. Physicians Eli Lilly to Launch Physician Payment Database Physician Payment Sunshine: Merck Joins the Act Medtronic to Voluntarily Disclose Payments to U.S. Physicians …but we can and MUST do better

The Physician Payments Sunshine Act An important first step towards transparency Key component of healthcare reform Levels the playing field Provides a uniform standard Proprietary information must be protected

12 Our evolving approach will continue to reinforce the benefits of collaboration while restoring the public trust CollaborationInnovation Improved Patient Outcomes [ REINFORCE [

Principled basis for industry and physician collaboration Sanctity of MD- patient relationship Minimize biases that could affect the objectivity required for optimum medical decision making Defined needs and roles All physician roles will be defined and disclosed to demonstrate their intentions All work will meet pre-specified needs Transparency and external oversight Physician activity will be documented and disclosed to the public Engage objective external medical, social, and ethical experts to review our practices We will continue to lead consistent with a set of principles that will guide our path forward

Angelina Henderson U.S. Cardiac Resynchronization Therapy to treat congestive heart failure Chima Miyaori Japan Microdebrider to remove tonsils causing sleep apnea Lina Tedesco Italy InterStim Therapy to treat voiding dysfunctions Renan Altendorff Brazil Insulin pump to control diabetes David Mangram U.S. Intrathecal Baclofen Therapy to treat symptoms of stroke Irene Chettiar India Activa DBS Therapy to treat Dystonia It’s not just about “Public” trust, it’s about THEIR trust